Dose-response studies on tolerance to multiple doses of secobarbital and methaqualone in a polydrug abuse population. 1979

T P Faulkner, and J H Hayden, and C M Mehta, and D A Olson, and E G Comstock

Patients from a polydrug abuse treatment program were titrated with either secobarbital or methaqualone, their primary drug of abuse, to a state of mild intoxication, consisting of lateral and vertical nystagmus, ataxia, slurred speech, and drownsiness. The mean dose required to produce each sign was compared to that determined in a similarly treated control group. Tolerance to secobarbital was more easily demonstrated than tolerance to methaqualone, and nystagmus was the least sensitive indicator of patient tolerance. The individual signs were also cumulated into a graded rating scale of central nervous system depression which would be related to the dose administered. Tolerence was easily demonstrated at the higher stages of toxicity for secobarbital in the overall patient population, but tolerance to methaqualone was only unequivocal in the subjects indicating a relatively high frequency of abuse. Tolerance to methaqualone occurred at the lower stages of toxicity, suggesting that there is a difference between tolerance to secobarbital and tolerance to methaqualone. There was no indication that patients who also abuse alcohol are more tolerant than their patient counterparts. The patients who also had a history of amphetamine abuse, however, were less tolerant than the nonusers of these drugs.

UI MeSH Term Description Entries
D008297 Male Males
D008702 Methaqualone A quinazoline derivative with hypnotic and sedative properties. It has been withdrawn from the market in many countries because of problems with abuse. (From Martindale, The Extra Pharmacopoeia, 30th ed, p604) Metolquizolone,Ortonal,Methaqualone Hydrochloride,Optimil,Quaalude,Hydrochloride, Methaqualone
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012631 Secobarbital A barbiturate that is used as a sedative. Secobarbital is reported to have no anti-anxiety activity. Meballymal,Quinalbarbitone,Sebar,Secobarbital Sodium,Seconal,Seconal Sodium,Sodium, Secobarbital
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

T P Faulkner, and J H Hayden, and C M Mehta, and D A Olson, and E G Comstock
January 1983, Journal of analytical toxicology,
T P Faulkner, and J H Hayden, and C M Mehta, and D A Olson, and E G Comstock
January 1969, Psychopharmacologia,
T P Faulkner, and J H Hayden, and C M Mehta, and D A Olson, and E G Comstock
August 1974, Clinical pharmacology and therapeutics,
T P Faulkner, and J H Hayden, and C M Mehta, and D A Olson, and E G Comstock
January 1994, Clinical EEG (electroencephalography),
T P Faulkner, and J H Hayden, and C M Mehta, and D A Olson, and E G Comstock
January 1978, Proceedings of the Western Pharmacology Society,
T P Faulkner, and J H Hayden, and C M Mehta, and D A Olson, and E G Comstock
August 1967, Arzneimittel-Forschung,
T P Faulkner, and J H Hayden, and C M Mehta, and D A Olson, and E G Comstock
January 1977, Advances in experimental medicine and biology,
T P Faulkner, and J H Hayden, and C M Mehta, and D A Olson, and E G Comstock
June 1971, Clinical toxicology,
T P Faulkner, and J H Hayden, and C M Mehta, and D A Olson, and E G Comstock
January 1975, Pharmacology, biochemistry, and behavior,
T P Faulkner, and J H Hayden, and C M Mehta, and D A Olson, and E G Comstock
April 1974, Journal of pharmacokinetics and biopharmaceutics,
Copied contents to your clipboard!